Dr Tom Gilhooly has been invited to be a member of the Hubbard Foundation Scientific Board which meets annually in San Diego. This board will help the Foundation to direct future research in relation to its work on fMRI, CCSVI and MS. His previous membership of UK and Scottish Government committees on Addiction will be useful in making a significant contribution to this prestigious scientific board. The Hubbard Foundation are particularly interested in the nutritional aspects of Dr Gilhooly's work in the context of MS to enhance the holistic approach to the disease.
 
Dr Gilhoolly commented
" It is a great honour to be invited onto the Scientific Board of the Hubbard Foundation. David Hubbard's presentation at the First Conference of the International Society of Neurovascular Disease in Bologna was one of the most memorable. His description of how CCSVI compliments the immune model of MS gives a clear way forward for those involved in MS management. Functional MRI could be a key objective method of assessing patient before and after angioplasty. Having such close links with an internationally respected organisation will help with the advancement of CCSVI treatment in the UK. "

The Hubbard Foundation was originally founded in 2007 to study the physiological mechanisms of cognition in the brain using functional magnetic resonance imaging, fMRI.  fMRI measures the blood flow within the brain itself and is used worldwide to study the live brain.  When David Hubbard MD, neurologist and founder of the Hubbard Foundation, and his wife Arlene Hubbard, an Occupational Therapist by training with a masters degree in counselling, learned their son had Multiple Sclerosis (MS), they decided to use the foundation and fMRI to investigate Multiple Sclerosis in order to find prevention, treatment and ultimately a cure for this disease.
 
Multiple Sclerosis (MS) is a chronic disease of the brain and spinal cord, causing physical and cognitive ailments.  Most treatments address the body’s immune system, but new research findings suggest the focus should shift to the vascular system, in particular the veins of the brain and spinal cord.  fMRI can be used to study these problems. In 2010, the Hubbard’s began using fMRI to study how to treat MS for the benefit of their son and people with MS battling this disease across the globe.
 
The mission of the Hubbard Foundation is to research the vascular component of neurological disorders, like Chronic Cerebrospinal Venous Insufficiency (CCSVI) in Multiple Sclerosis, using functional MRI (fMRI) as well MRV, flow-quantification, perfusion and other measures. Two papers on this topic are expected to be published later this year; both were submitted to two peer-reviewed Scientific journals respectively in early October 2011.  One paper discusses abnormalities in the cerebral blood flow of MS patients, and a return to normal following intervention.  The other will discuss clinical outcomes of venous intervention in MS patients with occluded head, neck, or chest veins.

The Hubbard Foundation's national Registry is continuing to collect data from over 20 sites across the US. Hubbard Foundation's research, as well as data from other physicians and researchers worldwide, is presented at the annual Conference in San Diego, educating not only people suffering from MS, but physicians and researchers.

http://us1.campaign-archive1.com/?u=646d7fd51cbebd959c3a5b033&id=667e636169&e=2a5edb0cf7